BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12552462)

  • 21. Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool.
    Yamazaki S; Kato S; Matsukura N; Ohtani M; Ito Y; Suto H; Yamazaki Y; Yamakawa A; Tokudome S; Higashi H; Hatakeyama M; Azuma T
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):261-8. PubMed ID: 15907447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CagA phosphorylation-dependent MMP-9 expression in gastric epithelial cells.
    Nam YH; Ryu E; Lee D; Shim HJ; Lee YC; Lee ST
    Helicobacter; 2011 Aug; 16(4):276-83. PubMed ID: 21762266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma.
    Lin WC; Tsai HF; Kuo SH; Wu MS; Lin CW; Hsu PI; Cheng AL; Hsu PN
    Cancer Res; 2010 Jul; 70(14):5740-8. PubMed ID: 20587516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA.
    Naito M; Yamazaki T; Tsutsumi R; Higashi H; Onoe K; Yamazaki S; Azuma T; Hatakeyama M
    Gastroenterology; 2006 Apr; 130(4):1181-90. PubMed ID: 16618412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering.
    Tammer I; Brandt S; Hartig R; König W; Backert S
    Gastroenterology; 2007 Apr; 132(4):1309-19. PubMed ID: 17408661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity.
    Saadat I; Higashi H; Obuse C; Umeda M; Murata-Kamiya N; Saito Y; Lu H; Ohnishi N; Azuma T; Suzuki A; Ohno S; Hatakeyama M
    Nature; 2007 May; 447(7142):330-3. PubMed ID: 17507984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA.
    Hatakeyama M
    Keio J Med; 2002 Dec; 51 Suppl 2():26-32. PubMed ID: 12528933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites.
    Cabral MM; Oliveira CA; Mendes CM; Guerra J; Queiroz DM; Rocha GA; Rocha AM; Nogueira AM
    Scand J Gastroenterol; 2007 May; 42(5):545-54. PubMed ID: 17454874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model.
    Shibata W; Hirata Y; Maeda S; Ogura K; Ohmae T; Yanai A; Mitsuno Y; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
    J Pathol; 2006 Nov; 210(3):306-14. PubMed ID: 16933206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.
    Higashi H; Tsutsumi R; Muto S; Sugiyama T; Azuma T; Asaka M; Hatakeyama M
    Science; 2002 Jan; 295(5555):683-6. PubMed ID: 11743164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genome-wide expression profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori.
    Sohn SH; Lee YC
    Environ Toxicol Pharmacol; 2011 Nov; 32(3):382-9. PubMed ID: 22004957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase.
    Tsutsumi R; Higashi H; Higuchi M; Okada M; Hatakeyama M
    J Biol Chem; 2003 Feb; 278(6):3664-70. PubMed ID: 12446738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity of the virulence factor cagA of Helicobacter pylori.
    Zhu YL; Zheng S; Qian KD; Fang PC
    Chin Med J (Engl); 2004 Sep; 117(9):1330-3. PubMed ID: 15377424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.
    Fujii Y; Murata-Kamiya N; Hatakeyama M
    Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori CagA protein variation associated with gastric cancer in Asia.
    Azuma T
    J Gastroenterol; 2004; 39(2):97-103. PubMed ID: 15069615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility.
    Poppe M; Feller SM; Römer G; Wessler S
    Oncogene; 2007 May; 26(24):3462-72. PubMed ID: 17160020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2.
    Shabelnik MY; Kostyuk OV; Merentsev SV; Tarasova TO; Sidorenko SP
    Exp Oncol; 2009 Sep; 31(3):134-9. PubMed ID: 19783969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori CagA--a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins.
    Hatakeyama M
    Microbes Infect; 2003 Feb; 5(2):143-50. PubMed ID: 12650772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between Helicobacter pylori CagA-SHP-2 interaction and gastric cancer].
    Hatakeyama M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():48-52. PubMed ID: 16363503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.